NCT03404570View on ClinicalTrials.gov

Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

January 18, 2019

Study Completion Date

January 18, 2019

Conditions
Palmar Hyperhidrosis
Interventions
DRUG

Dexmecamylamine HCl

Investigational drug

OTHER

Placebo

Oral tablet containing no active drug.

Trial Locations (3)

23502

Site 01, Norfolk

63122

Site 03, St Louis

92123

Site 02, San Diego

Sponsors
All Listed Sponsors
lead

Atacama Therapeutics

INDUSTRY

NCT03404570 - Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis | Biotech Hunter | Biotech Hunter